Next-generation incretin and metabolic research compounds — including dual and triple receptor agonists — synthesized to a higher standard and verified by third-party analysis.
This collection covers the next generation of incretin and metabolic research compounds — including single-molecule dual and triple receptor agonists such as Tirzepatide and Retatrutide, alongside the growth-hormone fragment AOD-9604. Each is supplied as a high-purity lyophilized powder for laboratory investigation of glucose homeostasis, energy balance and incretin signaling.
Every vial is synthesized to a high standard and released with a third-party certificate of analysis confirming identity and purity. All products on this page are sold strictly for laboratory research use — not for human or animal consumption.